Business context and reporting period
Prestige Brands Holdings, Inc. (the registrant named in the filing) markets and distributes OTC healthcare and household-cleaning products. This Form 10-Q covers the quarter and six months ended September 30, 2015, corresponding to fiscal Q2 and the first half of fiscal 2016. The filing is not under the company name “Prestige Consumer Healthcare Inc.” stated in the request metadata.
Financial performance and position
- Quarter: Revenue was $206.1 million, up 13.7% year over year; operating income was $69.9 million, up from $46.5 million; and net income was $31.8 million, up from $16.5 million. Diluted EPS was $0.60 versus $0.31.
- First half: Revenue was $398.2 million, up 21.8%; operating income was $132.4 million versus $89.3 million; and net income was $58.0 million versus $33.2 million. Diluted EPS was $1.09 versus $0.63.
- Margins: Gross margin was 58.2% for the quarter versus 56.6% a year earlier, and 58.3% for the six months versus 56.4%. Operating margin was approximately 34.0% versus 25.7% for the quarter and 33.2% versus 27.3% for the six months.
- Cash flow: First-half operating cash flow was $90.6 million, compared with $57.1 million. Investing used $1.3 million versus $810.5 million, largely reflecting the prior-year Insight and Hydralyte acquisitions. Financing used $87.6 million versus $747.2 million provided in the prior-year period. Cash increased $0.8 million to $22.2 million.
- Liquidity and debt: Current assets were $205.8 million and current liabilities $93.0 million at September 30. Debt principal was $1.504 billion, down from $1.594 billion at March 31; net debt carrying value, after unamortized issuance costs, was $1.472 billion. The ABL revolver had $26.1 million drawn and $87.2 million of available capacity. The company reported compliance with debt covenants.
- Other metrics: Interest expense was $20.7 million for the quarter and $42.6 million for the first half. The first-half effective tax rate was 35.2%, versus 41.2% in the prior year. Currency translation reduced first-half comprehensive income by $11.5 million.
Material changes versus prior comparable periods
- Insight, acquired in September 2014, contributed approximately $31.0 million of quarter revenue and $73.5 million of first-half revenue not present in the comparable prior-year periods. Revenue growth was therefore substantially acquisition-driven.
- North American OTC Healthcare revenue increased 19.0% for the quarter and 28.8% for the first half. International OTC revenue rose 1.5% and 2.4%, respectively. Household Cleaning revenue declined 6.2% for the quarter and 1.9% for the first half.
- Gross-margin improvement reflected favorable mix from Insight brands. General and administrative expense fell to $16.5 million for the quarter and $34.1 million for the first half, primarily because the prior year included higher Insight acquisition and integration costs.
- Interest expense increased year over year as average indebtedness remained higher following the Insight acquisition, despite a lower average borrowing cost. Debt principal declined during the current six-month period through net repayments.
Outlook, commentary, risks and unusual items
- No revenue or earnings guidance is provided in the filing. Management estimated an effective tax rate of approximately 35.4% for the remaining quarters of fiscal 2016, excluding acquisitions and discrete items, and anticipated covenant compliance in the normal course.
- Management reported that prior product shortages in women’s health and analgesics were resolved after increased manufacturing. It warned that renewed supply disruption could reduce sales and harm results.
- Management expects higher costs for certain products during the remainder of fiscal 2016 following a manufacturer notification; inability to offset these costs with pricing could pressure margins.
- Pediacare continued to face revenue and market-share declines amid competition, although the pace moderated. The company is monitoring the brand for impairment; no impairment charge was recorded in the first half. Goodwill and intangible assets totaled $2.407 billion, making future impairment assumptions important.
- Key risks include customer concentration (Walmart represented 19.6% of quarterly and 19.7% of first-half gross revenue, and 20.9% of receivables), dependence on third-party manufacturers and a third-party distribution center, variable-rate debt, foreign exchange exposure, regulation and product recalls. The company disclosed that it was conducting recalls for two products and was in early-stage discussions with regulators regarding a product-registration matter.
- A 1% increase in interest rates, with other factors held constant, would have increased first-half pre-tax expense and cash outflow by approximately $4.5 million. The CEO transition occurred June 1; a new CFO was announced for November 10, 2015. The filing also reports a $0.8 million additional compensation expense associated with accelerated vesting on the outgoing CEO’s retirement.
- The company early-adopted new debt-issuance-cost presentation guidance, reclassifying $27.4 million of deferred financing costs as a deduction from debt; this was a presentation change, not a reduction in principal owed.
Most important facts for investors to verify
- How much future growth is organic versus attributable to Insight, and whether acquired-brand performance and margins persist.
- Progress on Pediacare and other weaker brands, including any subsequent impairment indicators or charges.
- Debt reduction, revolver availability, floating-rate exposure and continued covenant compliance.
- Whether manufacturing cost increases, supply continuity, retailer concentration or regulatory and recall matters affect sales and margins.
- The assumptions supporting estimates for promotions, returns, inventory obsolescence and intangible-asset valuations.